Hericium erinaceus (Lion’s Mane) and Ganoderma lucidum (Reishi) are among the most thoroughly researched functional mushrooms available today. Both are found widely in supplement form, and both carry extensive traditional use histories in East Asian medicine. Yet their bioactive profiles, proposed mechanisms, and primary areas of scientific investigation differ considerably. This comparison examines the evidence for each species across the domains where they have been most studied, with the aim of providing a clearer framework for evaluating which may be more appropriate for a given health context.
The Core Biological Distinction
Before comparing applications, it is useful to understand the fundamental difference between these two species at the level of their primary bioactive compounds.
Lion’s Mane is uniquely characterized by two classes of neuroactive compounds: hericenones, found predominantly in the fruiting body, and erinacines, found in the mycelium. Both compound classes have been investigated in preclinical models for their ability to stimulate the synthesis of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), proteins that support neuronal survival, differentiation, and plasticity. The mushroom also contains polysaccharides with immunomodulatory properties, though neurotrophic activity is the primary focus of its modern research literature.[1]
Reishi’s bioactivity centers on two complementary compound classes: polysaccharides (particularly beta-1,3/1,6-glucans) and triterpenoids (including ganoderic acids and ganoderenic acids). The polysaccharide fraction is most associated with immune modulation via pattern recognition receptors, while the triterpenoid fraction has been investigated for anti-inflammatory, adaptogenic, and sedative-hypnotic effects. Reishi also contains ergosterol, proteins including the immunomodulatory LZ-8 lectin, and nucleosides with potential cardiovascular relevance.[2]
Cognitive Function: Where Lion’s Mane Leads
The cognitive and neurological research on Lion’s Mane is the more developed of the two species in this domain. Preclinical work has consistently demonstrated NGF-stimulating activity from both hericenone and erinacine fractions. More relevant for practical assessment, however, is the available human data.
A randomized, double-blind, placebo-controlled trial published in Biomedical Research assessed oral supplementation with H. erinaceus fruiting body in humans over 12 weeks. Mini Mental State Examination (MMSE) scores improved significantly in the supplementation group compared to the placebo group, and cognitive deterioration was attenuated. The authors speculated that the multiple bioactive compounds in the mushroom may exert effects on brain neural networks through several complementary pathways.[3]
Reishi does carry preclinical evidence relevant to neuroprotection and neurodegeneration, with research suggesting potential in epilepsy and neurodegenerative disease contexts, and its triterpenoids have been investigated for sedative effects. However, robust human clinical evidence for Reishi-specific cognitive outcomes comparable to the Lion’s Mane MMSE data has not yet been published.[2]
Practical Takeaway for Cognitive Goals
For individuals whose primary interest is cognitive function support, Lion’s Mane has a more specific and better-developed research basis. The evidence for Reishi in this domain is suggestive but less direct. It is also worth noting that the two compounds are not mutually exclusive: some researchers have proposed that Reishi’s potential neuroprotective anti-inflammatory activity could be complementary to Lion’s Mane’s neurotrophic effects, though direct human evidence for this combination specifically is limited.
Immune Modulation: Reishi’s Stronger Territory
When immune function is the primary consideration, the evidence profile shifts toward Reishi. The immunomodulatory activity of Ganoderma lucidum is among the most extensively documented in the functional mushroom literature, spanning decades of preclinical and clinical investigation.
Reishi polysaccharides activate macrophages, natural killer (NK) cells, and T lymphocytes through interactions with pattern recognition receptors including Dectin-1 and Toll-like receptors. Downstream effects include increased cytokine production, enhanced phagocytic activity, and promotion of adaptive immune responses. The triterpenoid fraction contributes anti-inflammatory activity by inhibiting nuclear factor-kappa B (NF-kB) and mitogen-activated protein kinase (MAPK) signaling pathways, providing a counterbalancing effect that may prevent excessive inflammatory cascades. Reishi also modulates gut microbiota in ways that research suggests may further influence systemic immune regulation.[4]
Lion’s Mane also contains beta-glucan polysaccharides with immune-relevant properties, and a comprehensive review of the species documents immunostimulating activity alongside its neurological effects.[1] However, the depth and specificity of immune research is greater for Reishi, and the breadth of clinical contexts in which Reishi’s immunomodulatory properties have been investigated is considerably wider.
Practical Takeaway for Immune Goals
For individuals whose primary focus is immune support, Reishi’s research portfolio is more extensive. Its dual mechanism via both polysaccharide and triterpenoid pathways, along with its documented gut microbiota interactions, suggests a multi-layered approach to immune modulation. Lion’s Mane may offer modest immune support as a secondary effect, but it is not the species where this particular research is most developed.
Stress, Sleep, and Adaptogenic Properties
Both species have research relevant to stress physiology, but through different mechanisms and to different degrees.
Reishi’s triterpenoids have been investigated for adaptogenic properties, with research examining potential effects on the hypothalamic-pituitary-adrenal (HPA) axis and associated cortisol regulation. Its ganoderic acid fractions have demonstrated sedative-hypnotic activity in preclinical models, and studies suggest these effects may operate through GABAergic pathways. The gut microbiota-serotonin axis has also been proposed as a mechanism by which Reishi polysaccharides may indirectly influence sleep architecture.
Lion’s Mane has human clinical data linking supplementation to improved mood and reduced anxiety scores in a specific population, and its NGF/BDNF-stimulating activity provides a plausible mechanism for mood regulation through neurotrophic pathways. Research suggests the two species may address stress-adjacent symptoms through different biological routes: Lion’s Mane more through neurotrophic signaling and serotonergic function, Reishi more through triterpenoid-mediated adaptogenic and direct sedative mechanisms.
Bioactive Compounds: A Side-by-Side Overview
Understanding which compounds drive each species’ effects can help inform product selection:
- Lion’s Mane key compounds: Hericenones (fruiting body), erinacines (mycelium), beta-glucans, polysaccharides. For full-spectrum activity, some researchers suggest products containing both fruiting body and mycelium fractions.
- Reishi key compounds: Beta-1,3/1,6-glucans, ganoderic acids, ganoderenic acids, ergosterol, LZ-8 protein. Dual-extraction products (water and ethanol) are relevant here, as polysaccharides require aqueous extraction while triterpenoids are captured more effectively by ethanol.
This difference in extraction requirements is practically significant. A Reishi product that has not been dual-extracted may contain a narrower spectrum of its bioactive compounds than a dual-extract product. For Lion’s Mane, extraction method matters too, but the fruiting body vs. mycelium question is equally important given that erinacines are concentrated in the mycelium rather than the fruiting body.
Safety and Tolerability
Both species have extended traditional use histories without documented serious adverse effects at typical supplementation levels. Available human studies for both have generally reported good tolerability.
Reishi has more documented potential interactions with certain medications: individuals taking anticoagulants or antiplatelet drugs, immunosuppressants, or medications for diabetes should be aware that Reishi’s immunomodulatory and potential blood-glucose effects could be relevant. Lion’s Mane has fewer reported interaction concerns in the literature, though individuals taking medications that affect serotonin function or NGF-related pathways should consult a healthcare provider.
For a broader look at how mushroom species may be used in combination rather than as alternatives, our overview of which functional mushrooms work better together covers the rationale and research context for multi-species approaches.
Which Should You Choose?
The answer depends primarily on the health context being considered:
- For cognitive support: Lion’s Mane has a more specific and clinically supported research base, with a human RCT demonstrating improvement in cognitive function scores.
- For immune modulation: Reishi’s extensive literature on polysaccharide and triterpenoid immunomodulatory mechanisms gives it a stronger position in this domain.
- For sleep and stress support: Reishi has more direct evidence via its triterpenoid and GABAergic mechanisms; Lion’s Mane may support these outcomes indirectly through mood and neurotrophic pathways.
- For general neuroprotection: Both species have relevant preclinical evidence; Lion’s Mane’s neurotrophic mechanism is more specific, while Reishi’s anti-inflammatory activity may offer broader neuroprotective support.
It is also worth noting that these species are not mutually exclusive. Given their distinct mechanisms, they are theoretically complementary rather than redundant, and a number of commercial formulations combine them. The appropriateness of a combined approach depends on individual health goals and should be evaluated in consultation with a healthcare provider, particularly when medications are involved.
References
- 1. Friedman M. Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion’s Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds. J Agric Food Chem. 2015;63(32):7108-23. PMID 26244378
- 2. Ahmad R, et al. Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties. Phytother Res. 2021;35(11):6030-6062. PMID 34411377
- 3. Saitsu Y, et al. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res. 2019;40(4):125-131. PMID 31413233
- 4. Zhao L, et al. Immunomodulatory Effects of Ganoderma lucidum Bioactive Compounds on Gut-Brain and Gut-Liver Axis Disorders. Curr Issues Mol Biol. 2025;47(10):842. PMID 41150791
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Functional mushroom supplements have not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Individual health needs vary; consult a qualified healthcare provider before starting any new supplement regimen, particularly if you are taking prescription medications or managing a health condition.
